comparemela.com

Latest Breaking News On - Roger li - Page 6 : comparemela.com

Dr Li on the Rationale for Evaluating CG0070 Plus Pembrolizumab in BCG-Unresponsive NMIBC

Roger Li, MD, expands on the mechanism of action for the combination of CG0070 and pembrolizumab, and discusses the rationale for investigating the regimen's synergy in patients with non–muscle invasive bladder cancer who are unresponsive to Bacillus Calmette-Guérin.

Private Equity Deal Drought Spurs Firms to Raise Cash Creatively

vimarsana © 2020. All Rights Reserved.